Key facts
- Wildflower Health’s last known valuation is $45.4M (Dec 2024).
- It has raised $58.8M across 2 recorded rounds; the latest was Early Stage VC ($17.9M) in Nov 2024.
- Notable investors include Kleiner Perkins, Hatteras Venture Partners, Echo Health Ventures, HealthTech Capital, Easton Capital Investment Group — 15 tracked in total.
- Wildflower Health has filed 2 Form Ds with the SEC since 2013, most recently Dec 2024 ($17.9M sold to 12 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Wildflower Health
Funding rounds
2 roundsAbout Wildflower Health
Developer of a health engagement platform designed for maternal and newborn health. The company leverages technology-based services to extend obstetrics practices and improve participation in the total cost-of-care models for obstetrics and newborn care, enabling medical professionals to promote healthy pregnancies, track family health, and support the growth of each family member based on their individual health needs over time.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2012
- Employees
- 70
- Website
- wildflowerhealth.com/
- Ownership
- Privately Held (backing)
Wildflower Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Wildflower Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Wildflower Health in its N-PORT filings yet. We sweep new filings monthly.